Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis.
Relocation of p25¿/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy.
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
Multiple Sclerosis: A Disease of Affluence?.
Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.
Multiple sclerosis and seizures: incidence and prevalence over 40 years.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.
Is anemia a probable cause of fatigue in patients with multiple sclerosis?
CD226 Gly307Ser Association With Neuromyelitis Optica in Southern Han Chinese.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
The Utility of Administrative Data for Surveillance of Comorbidity in Multiple Sclerosis: A Validation Study.
Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study.
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
The trees and the forest: Characterization of complex brain networks with minimum spanning trees.
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
Spatial modeling of multiple sclerosis for disease subtype prediction.
Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review.
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Prevalence of Incidental Narrowing of the Superior Segment of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Comparison of BLADE and conventional T2-TSE sequences for the sagittal visualization of the cervical spinal cord in multiple sclerosis patients - A case report.
Pathogenic CD8 T cells in multiple sclerosis and its experimental models.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
Pages
« first
‹ previous
…
274
275
276
277
278
279
280
281
282
…
next ›
last »